UTILISATION DU SR 49059, DE SES SOLVATS ET/OU HYDRATES PHARMACEUTIQUEMENT ACCEPTABLES, POUR LA PREPARATION DE MEDICAMENTS UTILES DANS LE TRAITEMENT OU LA PREVENTION DU PHENOMENE DE RAYNAUD

摘要

The invention relates to the use of (2S)-1- [(2R,3S)-5- chloro-3-(2-chlorophenyl)- 1-(3,4-dimethoxybenzenesulfonyl)- 3-hydroxy- 2,3-dihydro-1H-indole-2-carbonyl] pyrrolidine-2-carboxamide, the solvates thereof and/or pharmaceutically acceptable hydrates thereof in the production of medicaments used to treat or prevent Raynaud's phenomenon.